D.E. Shaw & Co
ARKG icon

D.E. Shaw & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

D.E. Shaw & Co’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Buy
450,224
+316,215
+236% +$10.1M 0.01% 1319
2026
Q1 		$3.55M Sell
134,009
-402,149
-75% -$11.8M ﹤0.01% 2440
2025
Q4 		$15.5M Buy
536,158
+335,424
+167% +$10.1M 0.01% 1413
2025
Q3 		$5.59M Buy
+200,734
New +$5.07M ﹤0.01% 2110

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

D.E. Shaw & Co's ARKG Position: Q2 2026 in Review

D.E. Shaw & Co increased its ARK Genomic Revolution ETF (ARKG) stake by 236% in Q2 2026, buying an estimated $10.1M and bringing the position to 450,224 shares worth $18.9M. The position accounts for 0.01% of the portfolio, ranked #1319.

D.E. Shaw & Co first reported a position in ARKG in Q3 2025 and has held it in 4 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • D.E. Shaw & Co held 450,224 shares of ARK Genomic Revolution ETF worth $18.9M as of Q2 2026.
  • D.E. Shaw & Co bought 316,215 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $10.1M.
  • ARK Genomic Revolution ETF made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1319 holding.
  • D.E. Shaw & Co first reported a position in ARK Genomic Revolution ETF in Q3 2025 and has held it in 4 quarters since.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.